DelveInsight’s “Acute Renal Failure Market Insights, Epidemiology and Market Forecast – 2032” report delivers an in-depth understanding of the Acute Renal Failure, historical and forecasted epidemiology as well as the Acute Renal Failure market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Key Highlights
-
Key Companies working on Acute Renal Failure Disease include Ionis Pharmaceuticals, Akcea Therapeutics, Novartis Pharmaceuticals, Arrowhead Pharmaceuticals, UniQure Biopharma B.V. and many others.
-
Key Therapies included in the Acute Renal Failure Disease market include WAYLIVRA (volanesorsen), Olezarsen, ARO-APOC3, and many others
Acute Renal Failure Disease Overview
Acute Kidney Failure occurs when your kidneys suddenly become unable to filter waste products from your blood. When your kidneys lose their filtering ability, dangerous levels of waste may accumulate, and your blood's chemical makeup may get out of balance.
Signs and symptoms of acute kidney injury differ depending on the cause and may include: Too little urine leaving the body, Swelling in legs, ankles, and around the eyes, Fatigue or tiredness, Shortness of breath, Confusion, Nausea, Seizures or coma in severe cases, Chest pain or pressure
Acute Renal Failure Disease Epidemiology Insights
-
The incidence of acute kidney injury was 50.1%, and 14.1% of the patients suffered from chronic kidney disease. The incidence of acute septic kidney injury was 75.3%. Mortality in patients with or without acute kidney injury was 41.8% and 14%, respectively (p < 0.001).
Click here to learn more about the Acute Renal Failure Disease Market Landscape
The Report Covers the Acute Renal Failure Disease Epidemiology Segmented by:
-
Acute Renal Failure Disease prevalent cases
-
Acute Renal Failure Disease incident cases
-
Acute Renal Failure Disease treatment cases
-
Acute Renal Failure Disease diagnosed cases
Acute Renal Failure Disease Market Outlook
The Acute Renal Failure (ARF) (Acute Kidney Injury) market outlook of the report helps to build a detailed comprehension of the historic, current and forecasted Acute Renal Failure (ARF) (Acute Kidney Injury) market trends by analyzing the impact of current Acute Renal Failure (ARF) (Acute Kidney Injury) therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Acute Renal Failure (ARF) (Acute Kidney Injury) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Acute Renal Failure (ARF) (Acute Kidney Injury) market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
Key Companies Working in the Acute Renal Failure Disease Market
-
Ionis Pharmaceuticals Inc.
-
Akcea Therapeutics
-
Novartis Pharmaceuticals
-
Arrowhead Pharmaceuticals
-
UniQure Biopharma B.V.
And many others
Acute Renal Failure Disease Therapies Covered and Analyzed in the Report
-
WAYLIVRA (volanesorsen)
-
Olezarsen
-
ARO-APOC3
And many others
Learn more about the Key Companies and Emerging Therapies in the Acute Renal Failure Disease Market
Table of Contents
-
Key Insights
-
Acute Renal Failure Disease Introduction
-
Executive Summary of Acute Renal Failure Disease
-
Disease Background and Overview
-
Epidemiology and patient population
-
Acute Renal Failure Disease Emerging Therapies
-
Acute Renal Failure Disease Market Outlook
-
Market Access and Reimbursement of Therapies
-
Market Drivers
-
Market Barriers
-
Appendix
-
Report Methodology
-
DelveInsight Capabilities
-
Disclaimer
Learn about the detailed offerings of the report Acute Renal Failure Disease Market Outlook
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email:Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services
